NewGenIvf Files Full H1 2026 Financials: $8.04M Net Loss, $6.88M Forbearance Liability
NIVF is trading near its 52-week low of $1.137 (1.3% above the low) on light trading volume (0.2× avg).
Summary
NewGenIvf's amended 6-K adds full H1 2026 financials: an $8.04 million net loss, $4.61 million of operating cash burn, $1.02 million of cash left, and a $6.88 million forbearance liability owed to JAK.
Key Events · Earnings and Guidance · NIVF
-
H1 2026 Net Loss of $8.04M
Net loss attributable to shareholders was $8,035,306 for the six months ended June 30, 2026, versus a $724,975 profit a year earlier.
-
One-Off JAK Forbearance Charge
A $3,421,643 loss on the Repurchase and Forbearance Agreement with JAK Opportunities VI LLC drove the swing; a $6,881,250 Repurchase Forbearance liability sits in current liabilities.
-
Cash Burn and Thin Liquidity
Operating activities used $4,607,447 of cash in H1 2026 versus $895,065 a year earlier, leaving $1,023,789 of cash and equivalents at June 30, 2026.
-
Margin Up, Revenue Down
Revenue fell 4.69% to $1,924,881 from $2,019,628, but gross margin rose to 24.1% from 15.5% on the Kyrgyzstan shift to referral services.
Analysis · NIVF · Industrial Applications And Services
This 6-K/A fills in the numbers behind the October 7 headline loss. Operating cash burn reached $4.61 million over six months against a $1.02 million cash balance at June 30, and the company carries a $6.88 million Repurchase Forbearance liability due to JAK. Revenue slipped 4.69% to $1.92 million, yet gross margin improved to 24.1% from 15.5% as the Kyrgyzstan business shifted from running a clinic to referral fees. Driving the loss is a $3.42 million one-off charge on the JAK repurchase and forbearance deal, not operations alone. With cash this thin and a steady stream of new convertible notes issued after quarter-end, continued financing is a dependency.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NIVF was trading at $1.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $1.14 to $22,636.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.